1-aminoindan has been researched along with selegiline in 2 studies
| Studies (1-aminoindan) | Trials (1-aminoindan) | Recent Studies (post-2010) (1-aminoindan) | Studies (selegiline) | Trials (selegiline) | Recent Studies (post-2010) (selegiline) |
|---|---|---|---|---|---|
| 18 | 0 | 8 | 2,575 | 319 | 394 |
| Protein | Taxonomy | 1-aminoindan (IC50) | selegiline (IC50) |
|---|---|---|---|
| Cholinesterase | Homo sapiens (human) | 0.0055 | |
| Cytochrome P450 3A4 | Homo sapiens (human) | 0.0039 | |
| Alpha-2A adrenergic receptor | Homo sapiens (human) | 1.798 | |
| Alpha-2B adrenergic receptor | Homo sapiens (human) | 0.376 | |
| Amine oxidase [flavin-containing] B | Rattus norvegicus (Norway rat) | 0.2127 | |
| Amine oxidase [flavin-containing] A | Rattus norvegicus (Norway rat) | 0.9046 | |
| Amine oxidase [flavin-containing] A | Homo sapiens (human) | 1.4408 | |
| Adenosine receptor A1 | Rattus norvegicus (Norway rat) | 0.0067 | |
| Amine oxidase [flavin-containing] B | Homo sapiens (human) | 0.1001 | |
| Type-1 angiotensin II receptor | Sus scrofa (pig) | 0.048 | |
| Alpha-synuclein | Homo sapiens (human) | 0.27 | |
| Amine oxidase [flavin-containing] B | Bos taurus (cattle) | 1 | |
| Sigma intracellular receptor 2 | Rattus norvegicus (Norway rat) | 0.017 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dimpfel, W; Hoffmann, JA | 1 |
| Kakish, J; Lee, JS; Tavassoly, O | 1 |
2 other study(ies) available for 1-aminoindan and selegiline
| Article | Year |
|---|---|
Electropharmacograms of rasagiline, its metabolite aminoindan and selegiline in the freely moving rat.
Topics: Animals; Brain Waves; Dose-Response Relationship, Drug; Indans; Monoamine Oxidase Inhibitors; Rats; Rats, Inbred F344; Selegiline | 2010 |
Rasagiline, a suicide inhibitor of monoamine oxidases, binds reversibly to α-synuclein.
Topics: alpha-Synuclein; Calorimetry; Indans; Methamphetamine; Monoamine Oxidase Inhibitors; Nanopores; Neuroprotective Agents; Protein Binding; Selegiline | 2015 |